Embolic protection, new stents, and TCAR are narrowing the gap between CAS and CEA, but medical therapy could still hold its own in CREST-2.
HOLLYWOOD, FL—Carotid artery stenting (CAS) and endarterectomy (CEA) remain neck and neck in vying for prominence, but some experts say a minimally invasive surgical approach known as transcarotid artery revascularization (TCAR), as well as new filters and devices that aim to cut the risk of minor stroke with stenting, could well shift the balance away from surgery.
Moreover, still-pending results from the CREST-2 trial will clarify the position of medical therapy compared with revascularization.
“We were running a little bit behind milestones, and I think right now we’re about right at milestones in terms of achieving the actual enrollment,” Barry T. Katzen, MD (Miami Cardiac & Vascular Institute, FL), reported at the 2019 International Symposium on Endovascular Therapy (ISET). “So this trial is moving along quite well, just slightly below the projected accrual rate. Interestingly enough, endarterectomy was lagging behind stenting in terms of accrual, but now it’s pretty much 50-50, which is great news for the ultimate statistical analysis of this trial.”
Read More: https://www.tctmd.com/news/surmounting-minor-stroke-new-devices-tcar-aim-cut-risk-carotid-artery-stenting
1NEWSISET 2019Surmounting Minor Stroke: New Devices, TCAR Aim to Cut Risk of Carotid Artery Stenting
Dr. Michael Aragon and Stacey Porter Bring Wealth of Clinical and Organizational Expertise During Time of Company Grow
A Silicon Valley startup that pioneered a new way to fight diabetes is tackling depression after its CEO noticed a disturbing trend
Via: Business Insider
When Sean Duffy, the cofounder and CEO of a digital-health startup called Omada Health, took his first look at the results of his new diabetes-treatment program, he noticed a disturbing trend.
Blue Cross Blue Shield of Massachusetts Adds Two New Digital Health Solutions for Large Self-insured Clients
Via: PR Newswire
BOSTON, Jan. 8, 2019 /PRNewswire/ -- Blue Cross Blue Shield of Massachusetts (Blue Cross) recently added two new digital health solutions to its Emerging Solutions portfolio—Robin Care for cancer support and Hinge Health for musculoskeletal conditions such as back and knee pain.
Transcarotid artery revascularization with a neuroprotection system was associated with a low rate of stroke in patients with carotid artery stenosis, according to 1-year results of the ROADSTER trial.